TotalMarketCap

Clinuvel Pharmaceuticals

CUVLNasdaq AustraliaMiscellaneousMiscellaneous

Market cap

$265.251 M

$5.26 +7.35%

Close of 6 Nov 2026

As of 6 Nov 2026, Clinuvel Pharmaceuticals (CUVL) has a market capitalization of $265.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$61.1M

#2650 by revenue

Earnings

$23.1M

#1810 by earnings

Shares outstanding

50,427,898

Latest filing cover page

P/E ratio

11.5

Cap ÷ net income

Miscellaneous, ranked by market cap

All 4 →
  1. #1Ferguson EnterprisesFERG$45.6B
  2. #2Clinuvel PharmaceuticalsCUVL$265.3M
  3. #3CDT Environmental Technology InvestmentCDTG$2.86M
  4. #4DecentDXST$2.21M

What if Clinuvel Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$559,945.49

Per share 106,454× higher

Bitcoin $1.53T

$30,297.68

Per share 5,760× higher

Apple $5.02T

$99,464.44

Per share 18,910× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Clinuvel Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.